Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN5A | Q14524 | 4/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 16/20 | 0.36 |
| ▸ | SCN1A | P35498 | 1/20 | 0.35 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22206343 | 0.94 | AOC3 (0.38) | SCN5AAOC3 | |
| SCHEMBL30641022 | 0.86 | AOC3 (0.34) | SCN5AAOC3 | |
| SCHEMBL22099141 | 0.86 | AOC3 (0.34) | SCN5AAOC3 | |
| Trifluoroacetic Acid SCHEMBL23736451 | 0.81 | SCN5A (0.38) | SCN5AAOC3SCN1ASCN2A | |
| Trifluoroacetic Acid SCHEMBL22206330 | 0.81 | SCN5A (0.37) | SCN5ASCN1ASCN2A | |
| Trifluoroacetic Acid SCHEMBL22206429 | 0.78 | SCN5A (0.35) | SCN5AAOC3SCN1ASCN2A | |
| Trifluoroacetic Acid SCHEMBL23736450 | 0.78 | KDM4E (0.36) | SCN5ASCN1ASCN2A | |
| SCHEMBL22206331 | 0.77 | SCN5A (0.36) | SCN5ASCN1ASCN2A | |
| SCHEMBL22099134 | 0.76 | SCN5A (0.40) | SCN5AAOC3SCN1ASCN2A | |
| Trifluoroacetic Acid SCHEMBL23736456 | 0.76 | PIK3CD (0.34) | SCN5AAOC3SCN1ASCN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11820769-B2 | Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same | YUHAN CORPORATION (KR) | 2023-11-21 | — | — | US | disclosed |
| US-20220024918-A1 | TRIAZOLOPYRIDIN-3-ONES OR THEIR SALTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | YUHAN CORPORATION (KR) | 2022-01-27 | — | — | US | disclosed |
| US-11091479-B2 | Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same | YUHAN CORPORATION (KR) | 2021-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11091479-B2 | Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same | VAPB, HDLBP, VAPA | SCN5A 2529/4885AOC3 51/4885SCN1A 1343/4885 |
| US-11820769-B2 | Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same | VAPB, HDLBP, VAPA | SCN5A 2529/4885AOC3 51/4885SCN1A 1343/4885 |
| US-20220024918-A1 | TRIAZOLOPYRIDIN-3-ONES OR THEIR SALTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | VAPB, HDLBP, VAPA | SCN5A 2529/4885AOC3 51/4885SCN1A 1343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.